Radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician

Published:2004-01 Issue:1 Volume:34 Page:2-3
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Conti Peter S.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference5 articles.

1. Radioimmunoscintigraphy and radioimmunotherapy in cancer;Potamianos;Anticancer Res,2000

2. Zevalin (ibritumomab tiuxetan) prescribing information,2002

3. Radioimmunotherapy for lymphoma;Zelenetz;Curr Opin Oncol,1999

4. Expression of human B cell-associated antigens on leukemias and lymphomas;Anderson;Blood,1984

5. Administration guidelines for radioimmunotherapy of non-Hodgkin’s lymphoma with 90Y-labeled anti-CD20 monoclonal antibody;Wagner;J Nucl Med,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Volumetric Properties for the Aqueous Solution of Yttrium Trichloride at Temperatures from 283.15 to 363.15 K and Ambient Pressure;Journal of Chemistry;2021-11-09

2. Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma;Oncology;2017

3. Radiolabeling of rituximab with 188Re and 99mTc using the tricarbonyl technology;Nuclear Medicine and Biology;2011-01

4. IMAGE QUANTIFICATION FOR RADIATION DOSE CALCULATIONS—LIMITATIONS AND UNCERTAINTIES;Health Physics;2010-11

5. Yttrium-90 Ibritumomab Tiuxetan as a Single Agent in Patients With Pretreated B-Cell Lymphoma: Evaluation of the Long-Term Outcome;Clinical Lymphoma Myeloma and Leukemia;2010-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3